CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
The purpose of this study is to evaluate the safety and efficacy of long-term treatment with IMG-007 in participants with moderate-to-severe atopic d...
Phase 2
Rolling Meadows, Illinois, United States and 22 other locations
The purpose of this study is to evaluate the efficacy and safety of different dose regimens of IMG-007, compared to placebo.
Phase 2
Rolling Meadows, Illinois, United States of America and 39 other locations
This is a phase 2b, multicenter, randomized, double-blind, placebo-controlled study.
Phase 2
Skokie, Illinois, United States and 84 other locations
The main purpose of this study is to measure the effect, safety and how well the body absorbs lebrikizumab in pediatric participants 6 months to \<18...
Phase 3
Chicago, Illinois, United States and 88 other locations
The main purpose of this study is to assess the long-term safety and efficacy of lebrikizumab in participants 6 Months to \<18 years of age with mode...
Phase 3
Chicago, Illinois, United States and 95 other locations
This is a Phase 1b, randomized, placebo/vehicle-controlled, double-blinded, multi-center trial. It is designed to assess the safety and efficacy of S...
Phase 1
Chicago, Illinois, United States and 7 other locations
The purpose of this study is to assess the efficacy and safety of barzolvolimab in adults with Atopic Dermatitis
Phase 2
Chicago, Illinois, United States of America and 36 other locations
Single center, prospective, Open label study of sleep, pruritus and circadian function pre/post 12-weeks of dupilumab treatment in children 6-17 year...
Phase 4
Chicago, Illinois, United States
(age 12 and older) with moderate-to-severe atopic dermatitis (eczema). Ebglyss is approved by the U.S. Food and Drug Administration, and its...
Phase 4
Libertyville, Illinois, United States and 9 other locations
The objective of this study is to assess the efficacy and safety of upadacitinib combined with topical corticosteroids (TCS) for the treatment of ado...
Phase 3
Chicago, Illinois, United States and 193 other locations
Clinical trials
Research sites
Resources
Legal